Beneficial Effect of Taurine Treatment Against Doxorubicin-Induced Cardiotoxicity in Mice

被引:32
作者
Ito, Takashi [1 ,2 ]
Muraoka, Satoko
Takahashi, Kyoko
Fujio, Yasushi
Schaffer, Stephen W.
Azuma, Junichi
机构
[1] Osaka Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharmacol & Pharmacogenom, Suita, Osaka 565, Japan
[2] Univ S Alabama, Dept Pharmacol, Mobile, AL 36688 USA
来源
TAURINE 7 | 2009年 / 643卷
关键词
MUSCLE GENE-EXPRESSION; OXIDATIVE STRESS; HYPERTROPHIC SIGNAL; CARDIAC MYOCYTES; HEART; TRANSCRIPTION; APOPTOSIS; METALLOTHIONEIN; OVEREXPRESSION; CARDIOMYOPATHY;
D O I
10.1007/978-0-387-75681-3_7
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Though the administration of taurine is clinically efficacious against heart failure, the mechanism underlying its cardioprotection remains to be established. To provide information on the mechanism, we examined the effects of taurine on doxorubicin (DOX)-induced cardiotoxicity, with an emphasis on ROS generation and cardiac gene inhibition. Oral administration of taurine (3% w/v in tap water) dramatically reduced the mortality rate in both the acute or sub-acute toxic models of DOX toxicity. It was shown that taurine prevented DOX-induced oxidative stress as determined froth cardiac glutathione content. Interestingly, Northern blot analysis revealed that DOX altered cardiac gene expression, including that of alpha-myosin heavy chain, ventricular myosin light chain-2 isoform and brain natriuretic peptide, an effect partially ameliorated by taurine treatment. In conclusion, taurine suppresses ROS generation and regulates gene expression in the DOX treated heart.
引用
收藏
页码:65 / 74
页数:10
相关论文
共 35 条
[1]  
ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548
[2]   Sarcoplasmic reticulum genes are selectively down-regulated in cardiomyopathy produced by doxorubicin in rabbits [J].
Arai, M ;
Tomaru, K ;
Takizawa, T ;
Sekiguchi, K ;
Yokoyama, T ;
Suzuki, T ;
Nagai, R .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1998, 30 (02) :243-254
[3]   Essential role of GATA-4 in cell survival and drug-induced cardiotoxicity [J].
Aries, A ;
Paradis, P ;
Lefebvre, C ;
Schwartz, RJ ;
Nemer, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (18) :6975-6980
[4]   TAURINE FOR TREATMENT OF CONGESTIVE HEART-FAILURE [J].
AZUMA, J ;
HASEGAWA, H ;
SAWAMURA, A ;
AWATA, N ;
HARADA, H ;
OGURA, K ;
KISHIMOTO, S .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 1982, 2 (02) :303-304
[5]   Conversion of taurine into N-chlorotaurine (taurine chloramine) and sulphoacetaldehyde in response to oxidative stress [J].
Cunningham, C ;
Tipton, KF ;
Dixon, HBF .
BIOCHEMICAL JOURNAL, 1998, 330 :939-945
[6]  
EDMONDSON DG, 1994, DEVELOPMENT, V120, P1251
[7]   PHYSIOLOGICAL ACTIONS OF TAURINE [J].
HUXTABLE, RJ .
PHYSIOLOGICAL REVIEWS, 1992, 72 (01) :101-163
[8]   DOXORUBICIN SELECTIVELY INHIBITS MUSCLE GENE-EXPRESSION IN CARDIAC-MUSCLE-CELLS INVIVO AND INVITRO [J].
ITO, H ;
MILLER, SC ;
BILLINGHAM, ME ;
AKIMOTO, H ;
TORTI, SV ;
WADE, R ;
GAHLMANN, R ;
LYONS, G ;
KEDES, L ;
TORTI, FM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (11) :4275-4279
[9]   Expression of taurine transporter is regulated through the TonE (tonicity-responsive element)/TonEBP (TonE-binding protein) pathway and contributes to cytoprotection in HepG2 cells [J].
Ito, T ;
Fujio, Y ;
Hirata, M ;
Takatani, T ;
Matsuda, T ;
Muraoka, S ;
Takahashi, K ;
Azuma, J .
BIOCHEMICAL JOURNAL, 2004, 382 :177-182
[10]   Suppression of cardiotoxicity by overexpression of catalase in the heart of transgenic mice [J].
Kang, YJ ;
Chen, Y ;
Epstein, PN .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (21) :12610-12616